THE MEDICAL NEWS

JMIR Publications today featured a critical new story in its News and Perspectives section examining the recent waves of disruption to inclusive clinical trials and the emerging strategies to keep health equity on track.

A new study from health policy researchers at the Brown University School of Public Health suggests that while regulators have several tools at their disposal to penalize insurance plans that break the rules, they rely mostly on relatively small financial penalties that may do little to deter violations.

The Alliance for Clinical Trials in Oncology is now enrolling patients in the ASPIRE trial (A032302)-a large-scale, phase III clinical study investigating whether adding chemotherapy to current standard treatments extends survival for men with advanced prostate cancer.

It took the better part of a century for maternal mortality to be recognized, forgotten and finally recognized again as an urgent public health crisis in the United States.

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss.

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults.

Researchers from University of California San Diego have found that microdosing - taking very small amounts of psychoactive substances - is more common among U.S. adults than previously recognized, with cannabis leading by a wide margin.